SCHEMBL584206

SCHEMBL584206

N#Cc1ccc(Cl)cc1C=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 4/20 0.52
TDP1 Q9NUW8 1/20 0.50
VCAM1 P19320 1/20 0.49
MAOA P21397 2/20 0.42
MAOB P27338 2/20 0.42
GPR35 Q9HC97 1/20 0.41
CYP2A6 P11509 1/20 0.41
NOS2 P35228 1/20 0.39
TRPV4 Q9HBA0 1/20 0.38
MCL1 Q07820 1/20 0.38
PTPN1 P18031 1/20 0.38
HSD17B10 Q99714 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
PSMB8 P28062 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29955194 0.84 TDP1 (0.55) ERN1TDP1VCAM1MAOAMAOB
SCHEMBL11358448 0.84 TDP1 (0.55) ERN1TDP1VCAM1MAOAMAOB
SCHEMBL26635210 0.80 XDH (0.47) ERN1TDP1VCAM1MAOAMAOB
SCHEMBL16958095 0.80 VCAM1 (0.44) ERN1VCAM1MAOAMAOBGPR35
SCHEMBL22686751 0.80 ERN1 (0.52) ERN1TDP1VCAM1PTPN1HSD17B10
SCHEMBL16956740 0.80 VCAM1 (0.44) ERN1TDP1VCAM1MAOAMAOB
SCHEMBL12352524 0.80 VCAM1 (0.44) TDP1VCAM1MAOAMAOBGPR35
SCHEMBL11485632 0.78 AHR (0.45) VCAM1MAOAMAOBGPR35CYP2A6
SCHEMBL11485637 0.78 AHR (0.45) VCAM1MAOAMAOBGPR35CYP2A6
SCHEMBL29531968 0.78 ERN1 (0.42) ERN1TDP1VCAM1GPR35HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107382820-B Synthetic method of 3-aryl isoindole derivative Changzhou University (CN) 2019-12-06 CN claimed
US-20260132112-A1 COMPOUNDS CTXT PTY LTD (AU) 2026-05-14 US disclosed
EP-4077318-B1 BENZIMIDAZOLE DIMERS AS MODULATORS OF STING CTXT PTY LTD (AU) 2025-10-15 EP disclosed
US-12415785-B2 Compound modulators of sting CTXT PTY LTD (AU) 2025-09-16 US disclosed
CN-114981265-B Compounds of formula (I) CTXT私人有限公司 2025-01-03 CN disclosed
US-20230062932-A1 COMPOUNDS CTXT PTY LTD. (AU) 2023-03-02 US disclosed
US-20230062932-A1 COMPOUNDS CTXT PTY LTD. (AU) 2023-03-02 US disclosed
WO-2022266711-A1 SUBSTITUTED AMIDOBENZIMIDAZOLE DIMERS AS STING MODULATORS Aculeus Therapeutics Pty Ltd (AU) 2022-12-29 WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-4077318-A1 COMPOUNDS CTXT PTY LTD (AU) 2022-10-26 EP disclosed
CN-114981265-A Compound (I) CTXT私人有限公司 2022-08-30 CN disclosed
WO-2021119753-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2021-06-24 WO disclosed
CN-110627720-A Synthesis method of 1-amino polysubstituted isoquinoline compound 兰州大学 2019-12-31 CN disclosed
CN-107382820-B Synthetic method of 3-aryl isoindole derivative Changzhou University (CN) 2019-12-06 CN disclosed
CN-108250127-A A kind of preparation method of isoindoline ketone compound and its derivative 陕西师范大学 2018-07-06 CN disclosed
US-20120077989-A1 CYCLIC IMIDATE LIGANDS UNIVERSITEIT GENT (BE) 2012-03-29 US disclosed
EP-2416879-A1 CYCLIC IMIDATE LIGANDS Universiteit Gent (BE) 2012-02-15 EP disclosed
WO-2010115903-A1 CYCLIC IMIDATE LIGANDS UNIVERSITEIT GENT (BE) 2010-10-14 WO disclosed
US-4244966-A 1,3-Dihydro-3-(2-hydroxy-, 2-bromo- or 2-chloroethyl)-2H-isoindol-1-one derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 1981-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415785-B2 Compound modulators of sting STING1, IRF3, MAVS ERN1 681/4885TDP1 533/4885VCAM1 2507/4885
US-20120077989-A1 CYCLIC IMIDATE LIGANDS IDH2, CYCS, NAPRT ERN1 1168/4885TDP1 3931/4885VCAM1 4761/4885
US-20260132112-A1 COMPOUNDS STING1, IRF3, CGAS ERN1 669/4885TDP1 112/4885VCAM1 2109/4885
US-20230062932-A1 COMPOUNDS STING1, IRF3, MAVS ERN1 984/4885TDP1 404/4885VCAM1 1333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.